Vancomycin–Teixobactin Conjugates
Authors:
Open Access
- 14 February 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (8) , 6343-6348
Abstract
Vancomycin continues to be a widely used antibiotic of last resort in treating drug-resistant pathogens despite the emergence of vancomycin-resistant strains such as vancomycin-resistant Enterococci (VRE). This communication reports that conjugation of vancomycin to a second antibiotic that targets a different region of lipid II enhances and rescues its antibiotic activity. Conjugation of vancomycin to a minimal teixobactin pharmacophore in which residues 1-6 are replaced with an aromatic amide results in substantial enhancement in activity over the individual components or mixtures thereof. Three conjugates with minimum inhibitory concentrations (MICs) of 0.5 μg/mL against methicillin-resistant Staphylococcus aureus (MRSA) and 0.063-0.125 μg/mL against methicillin-susceptible Staphylococcus aureus (MSSA) were identified. Each of these conjugates is also active against VRE, even though the individual components are inactive, with the most active conjugate (Cbp-Lys10-teixo7-11-vanco) having an MIC of 2-4 μg/mL. These findings demonstrate that conjugation of vancomycin to a minimal teixobactin pharmacophore is an effective strategy for enhancing the activity of vancomycin against important Gram-positive pathogens.Keywords
Funding Information
- University of California, Irvine
This publication has 38 references indexed in Scilit:
- Total Synthesis of [Ψ[C(═NH)NH]Tpg4]Vancomycin and its (4-Chlorobiphenyl)methyl Derivative: Impact of Peripheral Modifications on Vancomycin Analogues Redesigned for Dual d-Ala-d-Ala and d-Ala-d-Lac BindingJournal of the American Chemical Society, 2014
- Product Quality of Parenteral Vancomycin Products in the United StatesAntimicrobial Agents and Chemotherapy, 2012
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac BindingJournal of the American Chemical Society, 2011
- A Redesigned Vancomycin Engineered for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant BacteriaJournal of the American Chemical Society, 2011
- The Vancomycin−Nisin(1−12) Hybrid Restores Activity against Vancomycin Resistant EnterococciBiochemistry, 2008
- Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility TestingAntimicrobial Agents and Chemotherapy, 2008
- Vancomycin resistance: occurrence, mechanisms and strategies to combat itExpert Opinion on Therapeutic Targets, 2003
- Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the storyChemistry & Biology, 1996
- Structure, biochemistry and mechanism of action of glycopeptide antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Vancomycin, a new antibiotic. I. Chemical and biologic properties.1955